BGM Group Ltd. has made a strategic acquisition in the field of artificial intelligence and insurance technology. The company has acquired AIX Inc.'s intelligent platform for a valuation of 1 billion RMB. This move is expected to expand BGM's capabilities beyond the pharmaceutical sector and drive growth in the digital landscape.
The acquisition includes AIX's subsidiaries, RONS Intelligent Technology and Shenzhen Xinbao Investment Management, which specialize in digital solutions for the financial and insurance industries. The transaction is expected to be completed by the end of 2024, allowing BGM to leverage AIX's technological advancements in healthcare and insurance.
BGM's CEO, Mr. Xin Chen, is optimistic about the collaboration and sees potential for AIX's digital innovations to transform the pharmaceutical sector. The partnership aims to deliver more efficient and intelligent solutions to the global market. AIX's CEO, Mr. Hu Yinan, believes that the partnership with BGM will extend the reach of their platform and unlock greater potential for AI applications beyond insurance. This aligns with national policies focused on elderly care and the silver economy.
RONS Technology, founded in 2009, is a leader in insurtech, while Xinbao Investment, established in 2004, offers a platform that integrates technology with insurance services. BGM's existing product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. The integration of AIX's intelligent technology with BGM's biopharmaceutical expertise is expected to create a new paradigm for the development of healthcare, medicine, and insurance.
The acquisition is expected to create new opportunities for both BGM and AIX, leveraging each other's strengths in the healthcare and insurance sectors. BGM's extensive presence in the global pharmaceutical market will provide additional application scenarios for RONS Technology and Xinbao Investment. The integration of intelligent technology is crucial in the evolving healthcare landscape, and BGM's acquisition reflects this trend. The collaboration between BGM and AIX is expected to set a precedent for future partnerships in the sector, emphasizing the importance of innovation in driving growth and improving service delivery.
Overall, BGM's acquisition of AIX's intelligent platform enhances its technological capabilities and diversifies its operations, positioning the company for success in the healthcare and insurance markets.